Galmed Pharmaceuticals
GLMD
#10330
Rank
A$4.52 M
Marketcap
$2.73
Share price
-0.18%
Change (1 day)
-58.11%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2024 (TTM): -A$9.36 Million

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$10.93 Million, an increase over its 2022 earnings that were of -A$28.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$9.36 Million-14.4%
2023 -A$10.93 Million-61.31%
2022 -A$28.25 Million-44.97%
2021 -A$51.33 Million12.85%
2020 -A$45.49 Million40.61%
2019 -A$32.35 Million109.19%
2018 -A$15.47 Million-20.47%
2017 -A$19.45 Million-27%
2016 -A$26.64 Million58.6%
2015 -A$16.8 Million16.7%
2014 -A$14.39 Million-47.94%
2013 -A$27.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.15 Billion 1,338.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$3.79 Billion 37,722.90%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-A$36.75 Million 267.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$8.93 Million-10.73%๐Ÿ‡บ๐Ÿ‡ธ USA